The relationship between diabetic retinopathy and diabetic nephropathy in a population-based study in Korea (KNHANES V-2, 3)

Investigative Ophthalmology and Visual Science

Volumn 55, Issue 10, 2014, Pages 6547-6553

  Lee, Won June ^a   Sobrin, Lucia ^b   Lee, Min Jeong ^c   Kang, Min Ho ^a   Seong, Mincheol ^a   Cho, Heeyoon ^a,b  

^a Hanyang University College of Medicine   (South Korea)

^b HARVARD MEDICAL SCHOOL   (United States)

^c Ajou University School of Medicine   (South Korea)

Author keywords

Diabetic nephropathy; Diabetic retinopathy; Epidemiological study; KNHANES; Microalbuminuria; Overt nephropathy

Indexed keywords

HEMOGLOBIN A1C; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; EYE EXAMINATION; EYE FUNDUS; FEMALE; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTENSION; KOREA; MACULAR EDEMA; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; UREA NITROGEN BLOOD LEVEL; ADOLESCENT; AGED; CHILD; CLINICAL TRIAL; COMPARATIVE STUDY; COMPLICATION; DIABETIC NEPHROPATHIES; HEALTH SURVEY; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; PROCEDURES; RETROSPECTIVE STUDY; RISK ASSESSMENT; SOUTH KOREA; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; DIABETIC NEPHROPATHIES; DIABETIC RETINOPATHY; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; PREVALENCE; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; YOUNG ADULT;

EID: 84908108227     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.14-15001     Document Type: Article

References (49)

1. Keane WF, Brenner BM, de Zeeuw D, et al. The risk of developing end-stage renal disease in patients with type 2 diabetes and nephropathy: the RENAAL study. Kidney Int. 2003;63:1499-1507.
2. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047-1053.
3. Kim DJ. The epidemiology of diabetes in Korea. Diabetes Metab J. 2011;35:303-308.
4. Choi YJ, Kim HC, Kim HM, et al. Prevalence and management of diabetes in Korean adults: Korea National Health and Nutrition Examination Surveys 1998-2005. Diabetes Care. 2009;32:2016-2020.
5. Girach A, Vignati L. Diabetic microvascular complications— can the presence of one predict the development of another? J Diabetes Complications. 2006;20:228-237.
6. Harris MI. Diabetes in America: epidemiology and scope of the problem. Diabetes Care. 1998;21:C11-C14.
7. El-Asrar AM, Al-Rubeaan KA, Al-Amro SA, Moharram OA, Kangave D. Retinopathy as a predictor of other diabetic complications. Int Ophthalmol. 2001;24:1-11.
8. Villar G, Garcia Y, Goicolea I, Vazquez JA. Determinants of development of microalbuminuria in normotensive patients with type 1 and type 2 diabetes. Diabetes Metab. 1999;25: 246-254.
9. Stephenson JM, Fuller JH, Viberti GC, Sjolie AK, Navalesi R. Blood pressure, retinopathy and urinary albumin excretion in IDDM: the EURODIAB IDDM Complications Study. Diabetologia. 1995;38:599-603.
10. Rossing P, Hougaard P, Parving HH. Risk factors for development of incipient and overt diabetic nephropathy in type 1 diabetic patients: a 10-year prospective observational study. Diabetes Care. 2002;25:859-864.
11. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289:2560-2572.
12. Diabetic Retinopathy Study Coordinating Center. Diabetic Retinopathy Study: Manual of Operations. Baltimore, MD: Diabetic Retinopathy Study Coordinating Center; 1972.
13. Early Treatment Diabetic Retinopathy Study Research Group. Grading diabetic retinopathy from stereoscopic color fundus photographs: an extension of the modified Airlie House classification. ETDRS report number10. Ophthalmology. 1991;98:786-806.
14. Klein R, Klein BE, Moss SE, Cruickshanks KJ. The Wisconsin Epidemiologic Study of diabetic retinopathy. XIV. Ten-year incidence and progression of diabetic retinopathy. Arch Ophthalmol. 1994;112:1217-1228.
15. Diabetic Retinopathy Study Group. Diabetic retinopathy study. Report Number 6. Design, methods and baseline results. Report Number 7. A modification of the Airlie House classification of diabetic retinopathy. Invest Ophthalmol Vis Sci. 1981;21:1-226.
16. Early Treatment Diabetic Retinopathy Study Research Group. Detection of diabetic macular edema. Ophthalmoscopy versus photography. ETDRS report number 5. Ophthalmology. 1989; 96:746-751.
17. American Diabetes Association. Report of the Expert Committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 1997;20:1183-1201.
18. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39:S1-S266.
19. Nickolas TL, Frisch GD, Opotowsky AR, et al. Awareness of kidney disease in the US population: findings from the National Health and Nutrition Examination Survey (NHANES) 1999 to 2000. Am J Kidney Dis. 2004;44:185-197.
20. Coresh J, Astor BC, Greene T, et al. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis. 2003;41:1-12.
21. Zhang X, Saaddine JB, Chou CF, et al. Prevalence of diabetic retinopathy in the United States, 2005-2008. JAMA. 2010;304: 649-656.
22. de Boer IH, Rue TC, Hall YN, et al. Temporal trends in the prevalence of diabetic kidney disease in the United States. JAMA. 2011;305:2532-2539.
23. Pedro RA, Ramon SA, Marc BB, Juan FB, Isabel MM. Prevalence and relationship between diabetic retinopathy and nephropathy, and its risk factors in the north-east of Spain, a population-based study. Ophthalmic Epidemiol. 2010;17: 251-265.
24. Kim JH, Kim DJ, Jang HC, Choi SH. Epidemiology of micro-and macrovascular complications of type 2 diabetes in Korea. Diabetes Metab J. 2011;35:571-577.
25. Rhee SY, Chon S, Kwon MK, et al. Prevalence of chronic complications in Korean patients with type 2 diabetes mellitus based on the Korean National Diabetes Program. Diabetes Metab J. 2011;35:504-512.
26. Jee D, Lee WK, Kang S. Prevalence and risk factors for diabetic retinopathy: the Korea National Health and Nutrition Examination Survey 2008-2011. Invest Ophthalmol Vis Sci. 2013; 54:6827-6833.
27. Lim S, Kim DJ, Jeong IK, et al. A nationwide survey about the current status of glycemic control and complications in diabetic patients in 2006: the Committee of the Korean Diabetes Association on the epidemiology of diabetes mellitus. Korean Diabetes J. 2009;33:48-57.
28. Lee KU, Park JY, Kim SW, et al. Prevalence and associated features of albuminuria in Koreans with NIDDM. Diabetes Care. 1995;18:793-799.
29. Liebl A, Neiss A, Spannheimer A, et al. Complications, comorbidity, and blood glucose control in type 2 diabetes mellitus patients in Germany—results from the CODE-2 study. Exp Clin Endocrinol Diabetes. 2002;110:10-16.
30. Van Acker K, Weyler J, De Leeuw I. The Diabetic Foot Project of Flanders, the northern part of Belgium: implementation of the St Vincent consensus. Sensibilisation and registration in diabetes centres. Acta Clin Belg. 2001;56:21-31.
31. Le Floch JP, Thervet F, Desriac I, Boyer JF, Simon D. Management of diabetic patients by general practitioners in France 1997: an epidemiological study. Diabetes Metab. 2000; 26:43-49.
32. Lundman B, Engstrom L. Diabetes and it’s complications in a Swedish county. Diabetes Res Clin Pract. 1998;39:157-164.
33. Detournay B, Cros S, Charbonnel B, et al. Managing type 2 diabetes in France: the ECODIA survey. Diabetes Metab. 2000; 26:363-369.
34. Henricsson M, Nilsson A, Groop L, Heijl A, Janzon L. Prevalence of diabetic retinopathy in relation to age at onset of the diabetes, treatment, duration and glycemic control. Acta Ophthalmol Scand. 1996;74:523-527.
35. Diabetes Control and Complications Trial Research Group. Progression of retinopathy with intensive versus conventional treatment in the diabetes control and complications trial. Ophthalmology. 1995;102:647-661.
36. Aldington SJ, Kohner EM, Meuer S, Klein R, Sjolie AK. Methodology for retinal photography and assessment of diabetic retinopathy: The EURODIAB IDDM complications study. Diabetologia. 1995;38:437-444.
37. Romero-Aroca P, Mendez-Marin I, Baget-Nernaldiz M, Fernendez-Ballart J, Santos-Blanco E. Review of the relationship between renal and retinal microangiopathy in diabetes mellitus patients. Curr Diabetes Rev. 2010;6:88-101.
38. Schmechel H, Heinrich U. Retinopathy and nephropathy in insulin-treated diabetic patients in relation to the type of diabetes. Diabetes Metab. 1993;19:138-142.
39. Romero P, Salvat M, Fernández J, Baget M, Martinez I. Renal and retinal microangiopathy after 15 years of follow-up study in a sample of Type 1 diabetes mellitus patients. J Diabetes Complications. 2007;21:93-100.
40. Kramer HJ, Nguyen QD, Curhan G, Hsu CY. Renal insufficiency in the absence of albuminuria and retinopathy among adults with type 2 diabetes mellitus. JAMA. 2003;289:3273-3277.
41. Retnakaran R, Cull CA, Thorne KI, Adler AI, Holman RR; UKPDS Study Group. Risk factors for renal dysfunction in type 2 diabetes. UK Prospective Diabetes Study 74. Diabetes. 2006; 55:1832-1839.
42. Thomas MC, Macisaac RJ, Jerums G, et al. Nonalbuminuric renal impairment in type 2 diabetic patients and in the general population (national evaluation of the frequency of renal impairment co-existing with NIDDM [NEFRON] 11). Diabetes Care. 2009;32:1497-1502.
43. de Boer IH, Rue TC, Hall YN, Heagerty PJ, Weiss NS, Himmelfarb J. Temporal trends in the prevalence of diabetic kidney disease in the United States. JAMA. 2011;305:2532-2539.
44. Bhalla V, Zhao B, Azar KM, et al. Racial/ethnic differences in the prevalence of proteinuric and nonproteinuric diabetic kidney disease. Diabetes Care. 2013;36:1215-1221.
45. Lövestam-Adrian M, Agardh E, Agardh CD. The temporal development of retinopathy and nephropathy in type 1 diabetes mellitus during 15 years diabetes duration. Diabetes Res Clin Pract. 1999;45:15-23.
46. Kanauchi M, Kawano T, Uyama H, Shiiki H, Dohi K. Discordance between retinopathy and nephropathy in type 2 diabetes. Nephron. 1998;80:171-174.
47. Sabanayagam C, Foo VH, Ikram MK, et al. Is chronic kidney disease associated with diabetic retinopathy in Asian adults? [published online ahead of print March 18, 2014]. J Diabetes. doi:10.1111/1753-0407.12148.
48. Lee WJ, Sobrin L, Kang MH, et al. Ischemic diabetic retinopathy as a possible prognostic factor for chronic kidney disease progression. Eye. 2014;28(9):1119-1125.
49. Penno G, Solini A, Zoppini G, et al. Renal Insufficiency And Cardiovascular Events (RIACE) Study Group. Rate and determinants of association between advanced retinopathy and chronic kidney disease in patients with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian multicenter study. Diabetes Care. 2012;35:2317-2323